Hello. Sign in to personalize your visit. New user? Register now.  
Human Gene Therapy
Transglutaminase 1 Delivery to Lamellar Ichthyosis Keratinocytes

To cite this article:
Keith A. Choate, Todd M. Kinsella, Mary L. Williams, Garry P. Nolan, Paul A. Khavari. Human Gene Therapy. December 1996, 7(18): 2247-2253. doi:10.1089/hum.1996.7.18-2247.

Full Text: • PDF for printing (3,000.4 KB) • PDF w/ links (1,062.3 KB)


Keith A. Choate1,2
Todd M. Kinsella3
Mary L. Williams4
Garry P. Nolan3
Paul A. Khavari1,2
Address reprint requests to: Dr. Paul A. Khavari, Chief, Dermatology Service [123], Palo Alto V.A. Medical Center, 3801 Miranda Ave, Palo Alto, CA 94304
03 07 1996 Received for publication July 3, 1996. 18 09 1996 Accepted after revision September 18, 1996.

ABSTRACT

Therapeutic gene delivery in severe genetic skin disease may require production of a uniformly corrected population of cells capable of regeneration of normal skin elements when returned to the host. To achieve this, we have used lamellar ichthyosis (LI), a disorder of epidermal differentiation recently associated with defects in keratinocyte transglutaminase (TGase1), as a prototype. We have used a high-efficiency retroviral delivery approach to uniformly restore normal levels of TGase1 expression to primary keratinocytes from severely affected LI patients previously lacking TGase1. Delivered TGase1 was correctly targeted to membrane association and restored patient cell transglutaminase activity levels to normal. Corrected primary LI patient keratinocytes also demonstrated restoration of previously defective involucrin cross-linking and in vitro measures of cornification to levels found in normal cells. These results indicate that efficient TGase1 delivery to early passage keratinocytes can produce a population of corrected LI patient cells. The capability to produce such cells may provide a basis for future efforts at gene therapy for genetic skin disease.

Overview summary

Production and characterization of uniformly corrected primary cells in vitro suitable for therapeutic return to patients with monogenic diseases can pose a significant challenge. The recently characterized transglutaminase 1 (TGase1)-deficient disorder, lamellar ichthyosis (LI), offers a prototype for development of this capability using keratinocytes from patients with this severe genetic skin disease. We show here that primary cells from LI patient skin can be rapidly engineered at high efficiency and without subsequent selection via a retroviral expression vector for TGase1. It is shown that this gene delivery restores measures of cellular functions to normal. This rapid and high-efficiency approach for corrective gene delivery to primary patient cells in vitro may serve as a model for efforts in the skin and other tissues.

Free first page

This paper was cited by:

Molecular genetics of the ichthyoses
Gabriele Richard
American Journal of Medical Genetics. Dec 2004, Vol. 131C, No. 1: 32-44
CrossRef
Gene transfer to epidermal stem cells: implications for tissue engineering
Stelios T Andreadis
Expert Opinion on Biological Therapy. Jul 2004, Vol. 4, No. 6: 783-800
CrossRef
Development of spliceosome-mediated RNA trans-splicing (SMaRTtm) for the correction of inherited skin diseases
G. Dallinger, M. Puttaraju, L. G. Mitchell, K. B. Yancey, C. Yee, A. Klausegger, H. Hintner, J. W. Bauer
Experimental Dermatology. Mar 2003, Vol. 12, No. 1: 37-46
CrossRef
Retroviral Gene Transfer to Human Epidermal Keratinocytes Correlates with Integrin Expression and Is Significantly Enhanced on Fibronectin
Bharat Bajaj, Shahram Behshad, Stelios T. Andreadis
Human Gene Therapy. Oct 2002, Vol. 13, No. 15: 1821-1831
Abstract | Full Text PDF | Reprints & Permissions
Animal Models for Skin Blistering Conditions: Absence of Laminin 5 Causes Hereditary Junctional Mechanobullous Disease in the Belgian Horse
Flavia Spirito, Alexandra Charlesworth, Keith Linder, Jean-Paul Ortonne, John Baird, Guerrino Meneguzzi
Journal of Investigative Dermatology. Oct 2002, Vol. 119, No. 3: 684-691
CrossRef
Membrane Type 1 Matrix Metalloproteinase Regulates Cellular Invasiveness and Survival in Cutaneous Epidermal Cells
Usha Nagavarapu, Kenneth Relloma, G. Scott Herron
Journal of Investigative Dermatology. May 2002, Vol. 118, No. 4: 573-581
CrossRef
Sustainable Systemic Delivery via a Single Injection of Lentivirus into Human Skin Tissue
Seung-Cheol Baek, Qun Lin, Paul B. Robbins, Hongran Fan, Paul A. Khavari
Human Gene Therapy. Aug 2001, Vol. 12, No. 12: 1551-1558
Abstract | Full Text PDF | Reprints & Permissions
Impact of Laminin 5 β3 Gene versus Protein Replacement on Gene Expression Patterns in Junctional Epidermolysis Bullosa
Paul B. Robbins, Shannon M. Sheu, Julia B. Goodnough, Paul A. Khavari
Human Gene Therapy. Jul 2001, Vol. 12, No. 11: 1443-1448
Abstract | Full Text PDF | Reprints & Permissions
Cutaneous gene transfer and therapy: the present and the future
Flavia Spirito, Guerrino Meneguzzi, Olivier Danos, Mauro Mezzina
The Journal of Gene Medicine. Feb 2001, Vol. 3, No. 1: 21-31
CrossRef
Genetic Correction of Inherited Epidermal Disorders
Paul A. Khavari
Human Gene Therapy. Nov 2000, Vol. 11, No. 16: 2277-2282
Abstract | Full Text PDF | Reprints & Permissions
Cultivation of human keratinocyte stem cells: current and future clinical applications
G. Pellegrini, S. Bondanza, L. Guerra, M. Luca
Medical & Biological Engineering & Computing. Dec 1998, Vol. 36, No. 6: 778-790
CrossRef
Sustainable cutaneous gene delivery
Helen Deng, Qun Lin, Paul A. Khavari
Nature Biotechnology. Jan 1998, Vol. 15, No. 13: 1388-1391
CrossRef
Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog
Hongran Fan, Anthony E. Oro, Matthew P. Scott, Paul A. Khavari
Nature Medicine. Aug 1997, Vol. 3, No. 7: 788-792
CrossRef
All articles
Previous Next